Doxycycline Prophylaxis · Sexually Transmitted Infections
Primary and study completion pushed from Jun 15, 2028 to Jun 30, 2029
WestatPhase 4 NCT06738407 Registry history of NCT06738407 on ClinicalTrials.gov (opens the registry)
Updated
6 active trials 5 recruiting 5 changes in 30 days
3 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 0 with minor changes only.
Primary and study completion pushed from Jun 15, 2028 to Jun 30, 2029
WestatPhase 4 NCT06738407 Registry history of NCT06738407 on ClinicalTrials.gov (opens the registry)
Updated
Phase changed: Phase 2 → not applicable
Also in this update: Recruitment opened
WestatNot applicable NCT07510048 Registry history of NCT07510048 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
WestatNot applicable NCT07438041 Registry history of NCT07438041 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06738407 | Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections | Gonorrhea | Recruiting | 2026-10-09 |
| Not applicable | ||||
| NCT07438041 | Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services | HIV | Recruiting | 2026-10-09 |
| NCT07510048 | Combatting HIV Or Other STIs Early (CHOOSE) | HIV | Recruiting | 2026-10-09 |
| NCT07728123 | Screen2Prevent (S2P) | HIV Infections | Recruiting | 2026-08-17 |
| NCT06444360 | Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active… | HIV | Recruiting | 2026-06-17 |
| Not specified | ||||
| NCT07543965 | Cohort of Repeat Donor Experiences (CORE) Study | Health Effects (Ferritin Levels, CRP Levels, iGg Levels, Self-reported Health) | Not Yet Recruiting | 2026-04-22 |